Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation—an observational study including 2044 patients by Marit Tveito & Robert Løvsletten Smith & Espen Molden & Gudrun Høiseth

Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation—an observational study including 2044 patients by Marit Tveito & Robert Løvsletten Smith & Espen Molden & Gudrun Høiseth

Author:Marit Tveito & Robert Løvsletten Smith & Espen Molden & Gudrun Høiseth
Format: pdf
Tags: Zuclopenthixol, Long-acting injectable, Age, CYP2D6 genotype
Publisher: European Journal of Clinical Pharmacology
Published: 2020-09-30T17:00:55+00:00


Download



Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.